×
About 57,276 results

ALLMedicine™ Psoriasis Center

Research & Reviews  24,547 results

Retention and survival rate of etanercept in psoriasis over 15 years and patient outcom...
https://doi.org/10.1111/dth.14623
Dermatologic Therapy; Onsun N, Güneş B et. al.

Dec 4th, 2020 - There have been a number of investigations of the efficacy and safety of etanercept. This study was performed to obtain long-term drug survival data (i.e. time to drug discontinuation) for etanercept, and the reasons for its discontinuation. The s...

Incorporating joint pain screening into the pediatric dermatologic examination.
https://doi.org/10.1111/pde.14454
Pediatric Dermatology REFERENCES; Rustad AM, Nolan BE et. al.

Dec 4th, 2020 - Joint manifestations are a feature of many pediatric skin disorders, among them psoriasis, autoimmune and autoinflammatory diseases, hypermobility disorders, and as an adverse effect of certain medications. Identifying joint disease early is impor...

Disease response and patient-reported outcomes among initiators of ixekizumab.
https://doi.org/10.1080/09546634.2020.1853023
The Journal of Dermatological Treatment; Shahriari M, Harrison RW et. al.

Dec 3rd, 2020 - There is limited real-world evidence on using ixekizumab in psoriasis patients. Therefore, we characterized patients with psoriasis initiating ixekizumab and report 6-month changes in disease and patient-reported outcomes. Adult patients with psor...

Progress in novel ultradeformable vesicular drug carrier in the topical and transdermal...
https://doi.org/10.4155/tde-2020-0081
Therapeutic Delivery; Nayak N, Somanna P et. al.

Dec 3rd, 2020 - Psoriasis is a chronic autoimmune condition that is described by infected skin patches. Ultradeformable vesicles have been a novel carrier for the treatment of psoriasis in topical and transdermal therapy. The systemic route may induce adverse eff...

The effects of selected biologics and a small molecule on Health-Related Quality of Lif...
https://doi.org/10.1371/journal.pone.0241604
PloS One; Karpińska-Mirecka A, Bartosińska J et. al.

Dec 3rd, 2020 - The Dermatology Life Quality Index (DLQI) is commonly used to assess the quality of life of patients with skin diseases. Clinical trials confirm the positive effect of the use of biologics and new molecules on the quality of life of patients with ...

see more →

Guidelines  193 results

Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function
https://onlinelibrary.wiley.com/doi/10.1002/acr2.11196
ACR Open Rheumatology; Liphardt AM

Nov 24th, 2020 - The objective of this study was to compare the impact of psoriatic disease (psoriatic arthritis [PsA] and psoriasis) and rheumatoid arthritis (RA) on objective and subjective parameters of hand function.

Bone Mineral Density, Osteoporosis, and Fracture Risk in Adult Patients with Psoriasis or Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Observational Studies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699147/
Journal of Clinical Medicine; Chen TL

Nov 18th, 2020 - Awareness of psoriasis-related comorbidities has been established in the current guidelines; however, evidence regarding the association of bone density or bone fragility with psoriatic disease remains inconclusive.

Risk of osteoarthritis in an incident cohort of people with psoriatic arthritis: a population-based cohort study
https://www.jrheum.org/content/early/2020/11/10/jrheum.200564
The Journal of Rheumatology; Charlton R

Nov 15th, 2020 - To determine the risk of a diagnosis of osteoarthritis (OA) in psoriatic arthritis (PsA) patients compared to patients with psoriasis and a general population cohort.

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Evaluation of the correlation between scales determining disease severity in patients with moderate-severe chronic plaque type psoriasis
https://pubmed.ncbi.nlm.nih.gov/33142051/
Journal of Cosmetic Dermatology; Gundogdu M

Nov 2nd, 2020 - Psoriasis is a chronic erythematous-squamous disease. The results of studies related with the correlation between methods used in determining disease severity are contradictory.

see more →

Drugs  1,267 results see all →

Clinicaltrials.gov  27,341 results

Retention and survival rate of etanercept in psoriasis over 15 years and patient outcom...
https://doi.org/10.1111/dth.14623
Dermatologic Therapy; Onsun N, Güneş B et. al.

Dec 4th, 2020 - There have been a number of investigations of the efficacy and safety of etanercept. This study was performed to obtain long-term drug survival data (i.e. time to drug discontinuation) for etanercept, and the reasons for its discontinuation. The s...

Incorporating joint pain screening into the pediatric dermatologic examination.
https://doi.org/10.1111/pde.14454
Pediatric Dermatology REFERENCES; Rustad AM, Nolan BE et. al.

Dec 4th, 2020 - Joint manifestations are a feature of many pediatric skin disorders, among them psoriasis, autoimmune and autoinflammatory diseases, hypermobility disorders, and as an adverse effect of certain medications. Identifying joint disease early is impor...

Disease response and patient-reported outcomes among initiators of ixekizumab.
https://doi.org/10.1080/09546634.2020.1853023
The Journal of Dermatological Treatment; Shahriari M, Harrison RW et. al.

Dec 3rd, 2020 - There is limited real-world evidence on using ixekizumab in psoriasis patients. Therefore, we characterized patients with psoriasis initiating ixekizumab and report 6-month changes in disease and patient-reported outcomes. Adult patients with psor...

Progress in novel ultradeformable vesicular drug carrier in the topical and transdermal...
https://doi.org/10.4155/tde-2020-0081
Therapeutic Delivery; Nayak N, Somanna P et. al.

Dec 3rd, 2020 - Psoriasis is a chronic autoimmune condition that is described by infected skin patches. Ultradeformable vesicles have been a novel carrier for the treatment of psoriasis in topical and transdermal therapy. The systemic route may induce adverse eff...

The effects of selected biologics and a small molecule on Health-Related Quality of Lif...
https://doi.org/10.1371/journal.pone.0241604
PloS One; Karpińska-Mirecka A, Bartosińska J et. al.

Dec 3rd, 2020 - The Dermatology Life Quality Index (DLQI) is commonly used to assess the quality of life of patients with skin diseases. Clinical trials confirm the positive effect of the use of biologics and new molecules on the quality of life of patients with ...

see more →

News  3,707 results

Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function
https://onlinelibrary.wiley.com/doi/10.1002/acr2.11196
ACR Open Rheumatology; Liphardt AM

Nov 24th, 2020 - The objective of this study was to compare the impact of psoriatic disease (psoriatic arthritis [PsA] and psoriasis) and rheumatoid arthritis (RA) on objective and subjective parameters of hand function.

Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years
https://www.staging.medscape.com/viewarticle/941377

Nov 19th, 2020 - The full 5-year results of a long-term extension study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5,400 patient-years of prospective follow-up, Diamont Thaç...

Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years
https://www.medscape.com/viewarticle/941377

Nov 19th, 2020 - The full 5-year results of a long-term extension study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5,400 patient-years of prospective follow-up, Diamont Thaç...

Bone Mineral Density, Osteoporosis, and Fracture Risk in Adult Patients with Psoriasis or Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Observational Studies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699147/
Journal of Clinical Medicine; Chen TL

Nov 18th, 2020 - Awareness of psoriasis-related comorbidities has been established in the current guidelines; however, evidence regarding the association of bone density or bone fragility with psoriatic disease remains inconclusive.

Risk of osteoarthritis in an incident cohort of people with psoriatic arthritis: a population-based cohort study
https://www.jrheum.org/content/early/2020/11/10/jrheum.200564
The Journal of Rheumatology; Charlton R

Nov 15th, 2020 - To determine the risk of a diagnosis of osteoarthritis (OA) in psoriatic arthritis (PsA) patients compared to patients with psoriasis and a general population cohort.

see more →

Patient Education  221 results see all →